Hologic (HOLX) closed the most recent trading day at $67.76, moving -1.25% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 2.71% for the day. On the other ...

TPG and Blackstone’s bid valued Hologic at $70–$72 per share, a premium to its $54.28 closing price. Hologic’s share price has declined 24% in 2024 amid tariff challenges and weakening demand.

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape characterized ...

Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The ...

MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas, October 21, 2025--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be ...

Hologic, Inc. (HOLX) is a leading global medical technology company headquartered in Marlborough, Massachusetts. Founded in 1985, Hologic is valued at a market cap of $12.9 billion and specializes in ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 30, 2023. “We delivered strong revenue and ...